21 CFR 522.1704
§ 522.1704 Pentosan polysulfate sodium.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.1704, § 522.1704 Pentosan polysulfate sodium, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87510
- Permanent ID
ys:prov:87510@1- SHA-256
5ddd1cd904849cf3b9b9c1dc4ef71e502269b1e4a8f10dd96ac8b1e2faa0832b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 250 milligrams (mg) of pentosan polysulfate sodium.
(b) Sponsor. See No. 043264 in § 510.600(c) of this chapter.
(c) Conditions of use—(1) Amount. Administer 3 mg per kilogram of body weight (1.4 mg per pound) by intramuscular injection once weekly for 4 weeks for a total of four doses.
(2) Indications for use. For the control of clinical signs associated with osteoarthritis in horses.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.